Evidence map›Paper›PMID 40480989›Full record

ArticleNature communications2025

Pd/C promotes C-H bond activation and oxidation of p-hydroxybenzoate during hydrogenolysis of poplar.

Canan Sener, Vitaliy I Timokhin, Jan Hellinger, John Ralph, Steven D Karlen

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Canan SenerWisconsin Energy Institute, University of Wisconsin, Madison, WI, USA.ORCID http://orcid.org/0000-0001-9567-2333
Vitaliy I TimokhinWisconsin Energy Institute, University of Wisconsin, Madison, WI, USA.
Jan HellingerWisconsin Energy Institute, University of Wisconsin, Madison, WI, USA.ORCID http://orcid.org/0000-0002-4489-6713
John RalphWisconsin Energy Institute, University of Wisconsin, Madison, WI, USA.ORCID http://orcid.org/0000-0002-6093-4521
Steven D KarlenWisconsin Energy Institute, University of Wisconsin, Madison, WI, USA. skarlen@wisc.edu.ORCID http://orcid.org/0000-0002-2044-8895

Funding

DOE | SC | Biological and Environmental Research (BER) DE-SC0018409Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) CRS115_180258
6 · The paper itself

Abstract

Hydrogenolysis of lignin generates a portfolio of products, the yields of which are generally calculated using a subset of phenolic monomers that are dependent on the lignin composition, product distribution, and analytical technique. Some lignins are naturally γ-acylated; poplar lignins, for example, have p-hydroxybenzoate groups on 1-15% of their syringyl subunits. Upon hydrogenolysis, it is generally assumed that the p-hydroxybenzoate is cleaved before the deacylated lignin is depolymerized. Hydrogenolysis of model γ-p-hydroxybenzoylated β-aryl ethers do not, however, produce the deacylated β-aryl ether intermediates, as was previously conjectured; products instead derive from palladium-assisted reactions on the cinnamyl p-hydroxybenzoates resulting in initial β-ether cleavage. The p-hydroxybenzoate moiety itself also undergoes carboxylate-assisted palladium-catalyzed C-H bond activation to form the 2,4-dihydroxybenzoate, that subsequently converts to the 2,4-dihydroxycyclohex-1-enoate. These details underscore previously unrecognized pathways and products that are key to understanding the different hydrogenolysis product distributions from naturally acylated lignins that are prevalent biomass-conversion feedstocks.

Identifiers

PMID40480989
PMCPMC12144255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.